Devon Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Devon Patel has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Catherine Devitt
Department of Anesthesiology, Stony Brook University Hospital, Health Sciences Center, Level 4, Room 060, Stony Brook, NY 11794, USA
1 shared publication - Daryn Moller
Department of Anesthesiology, Stony Brook University Hospital, Stony Brook, NY 11794, USA
1 shared publication - Rustin Mahboubi Ardakani
Stony Brook Medicine, Stony Brook, USA
1 shared publication - Shaji Poovathoor
Department of Anesthesiology, Stony Brook University Hospital, Health Sciences Center, Level 4, Room 060, Stony Brook, NY 11794, USA
1 shared publication - Zhaosheng Jin
Department of Anesthesiology, Stony Brook University Hospital, Stony Brook, NY 11794, USA
1 shared publication
Latest Publications
- Open Access
- 15 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (16) , 7888
Biomarkers and Clinical Evaluation in the Detection of Frailty
Frailty is a complex biological process that is associated with adverse outcomes in community-dwelling and hospitalized patients. While clinical evaluation is the current gold standard for screening and diagnosis, such an approach is not without its limitations (such as personnel and resource requirement). In this review, we will discuss prospective biomarkers for frailty. Opportunistic and deliberate radiological testing could provide important information that complements clinical frailty evaluation. Novel biochemical panels may yield additional methods for frailty screening in the future. It is known that early frailty intervention could lead to better outcomes for patients. Integration of electronic medical records, laboratory and radiological results, as well as clinical informatics infrastructure could result in augmented clinical decision-making and more optimized healthcare resources utilization.
- 15 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (16) , 7888
Open AccessBiomarkers and Clinical Evaluation in the Detection of Frailty
Frailty is a complex biological process that is associated with adverse outcomes in community-dwelling and hospitalized patients. While clinical evaluation is the current gold standard for screening and diagnosis, such an approach is not without its limitations (such as personnel and resource requirement). In this review, we will discuss prospective biomarkers for frailty. Opportunistic and deliberate radiological testing could provide important information that complements clinical frailty evaluation. Novel biochemical panels may yield additional methods for frailty screening in the future. It is known that early frailty intervention could lead to better outcomes for patients. Integration of electronic medical records, laboratory and radiological results, as well as clinical informatics infrastructure could result in augmented clinical decision-making and more optimized healthcare resources utilization.